https://drug-linkerconjugat.co....m/index.php/toxic-bo
The prognosis of HCC patients with main portal vein invasion (Vp4) is poor. We retrospectively reviewed the therapeutic effects with your new HAIC program in dealing with Vp4 HCC clients. of 5-fluorouracil (5-FU) using an infusion pump for 5 consecutive days) with Lipiodol embolization between 2002 and 2018. Twenty-two patients (31.0%) also got sorafenib. The Kaplan-Meier curve ended up being used to calculate progression-free survival (PFS) and ov
Curtir
Comentario
Compartilhar
